PNC FINANCIAL SERVICES GROUP, INC. - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$44,374
-21.6%
8,142
-3.4%
0.00%
Q2 2023$56,579
-6.4%
8,432
+23.2%
0.00%
Q1 2023$60,442
+14.9%
6,845
-0.6%
0.00%
Q4 2022$52,609
-17.8%
6,886
-22.4%
0.00%
Q3 2022$64,000
+100.0%
8,876
+127.6%
0.00%
Q2 2022$32,000
-56.2%
3,899
-26.3%
0.00%
Q1 2022$73,000
+37.7%
5,293
+176.7%
0.00%
Q4 2021$53,000
-70.4%
1,913
-63.5%
0.00%
Q3 2021$179,000
-43.2%
5,246
-32.0%
0.00%
Q2 2021$315,000
-19.8%
7,718
-20.9%
0.00%
Q1 2021$393,000
-33.2%
9,760
-1.7%
0.00%
-100.0%
Q4 2020$588,000
+90.3%
9,924
+56.0%
0.00%
Q3 2020$309,000
-4.0%
6,362
-4.1%
0.00%
Q2 2020$322,000
+1688.9%
6,635
+922.3%
0.00%
Q1 2020$18,000
-5.3%
649
+1.7%
0.00%
Q4 2019$19,000
-5.0%
638
-0.5%
0.00%
Q3 2019$20,0006410.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders